GSK3772847

Phase 2Small molecule

GSK

GSK3772847 is one of 75 small molecule programs targeting Lupus. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

LupusActive, not recruiting

AsthmaActive, not recruiting

Lupus NephritisActive, not recruiting

LupusPhase 2

Active, not recruiting

AsthmaPhase 2

Active, not recruiting

Lupus NephritisPhase 2

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Veramyst

GSK

Preclinical

46 2

Xolair

Roche

Preclinical

25 3

Singulair

AstraZeneca

Preclinical

17 4

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

35 5

Cinqair

Teva

Preclinical

13 6

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 7

Asmanex

Novartis

Preclinical

5 8

GSK3772847

GSK

Phase 2

2 9

Celexa

AbbVie

Preclinical

1 10

Spiriva

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma2 trials

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

Completed· GSK logo

GSK·Phase 2·NCT03207243·165 enrolled

Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)

Terminated· GSK logo

GSK·Phase 2·NCT03393806·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for GSK3772847. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — GSK3772847 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for GSK3772847. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: GSK

GSK3772847

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma2 trials

References

Drug Info

Quick Facts

Related News